• Lancet · Apr 2019

    Comment

    Infliximab biosimilar CT-P13 in Crohn's disease.

    • Krisztina B Gecse and Geert R D'Haens.
    • Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, 1105 AZ Amsterdam, Netherlands.
    • Lancet. 2019 Apr 27; 393 (10182): 1671-1672.

    no abstract available

      Pubmed     Full text   Copy Citation  

      Add institutional full text...

    Notes

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.